63323-104Level 3
Etoposide (ETOPOSIDE)
**Product type:** Human Prescription Drug
**Active ingredient:** ETOPOSIDE
**Strength:** 20 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Fresenius Kabi USA, LLC
**Marketing category:** ANDA (ANDA074983)
**Pharmacologic class:** Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/63323-104Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.